Tertiary Lymphoid Neogenesis in Human Lupus Nephritis
Tertiary Lymphoid Neogenesis in Human Lupus Nephritis
批准号:
8431406
负责人:
Marcus Ramsay Clark
金额:
$32.2万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-08-15 至 2014-06-30
关键词:
AntibodiesAntigen-Antibody ComplexAntigen-Presenting CellsAntigenic SpecificityAntigensApplications GrantsArthralgiaAutoantigensAutoimmune DiseasesAutoimmunityB cell repertoireB-Lymphocyte SubsetsB-LymphocytesBasement membraneBiopsyCell SeparationCerebritisCicatrixClinicalClonal ExpansionClone CellsCoupledDepositionDevelopmentDiffuseDiseaseExanthemaFollicular Dendritic CellsFramework RegionsGlomerulonephritisHealthHumanImmune responseImmunoglobulin Somatic HypermutationImmunoglobulin Variable RegionImmunoglobulinsIn SituInflammationInflammatory InfiltrateKidneyLasersLeftLifeLightLupusLupus NephritisLymphoidMicroscopyModelingMusNephritisOrgan failurePathogenesisPatientsPatternPeripheralPhenotypePneumoniaPopulationPrevalenceReverse Transcriptase Polymerase Chain ReactionSamplingStructure of germinal center of lymph nodeSystemic Lupus ErythematosusT-LymphocyteTestingTubular formationTubulointerstitial Nephritisinterstitialnoveloutcome forecastresponsevector
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The most frequent severe manifestation of SLE is lupus nephritis (LN). Pathologically, lupus nephritis (LN) is characterized by immune complex deposition and inflammation in both glomeruli and tubuluointersitium that, if left untreated, can result in scarring and irreversible organ failure. Of the pathological manifestations of LN, glomerulonephritis (GN) is both the best studied and the feature most often replicated in murine models of autoimmune disease. However, tubulointerstitial inflammation is also a usual feature of LN that contributes to overall disease activity and determines long-term prognosis. Myriad studies indicate that GN results from a systemic break in B cell tolerance and the local deposition of immune complexes containing antibodies reactive with ubiquitous self-antigens. However, the pathogenesis of SLE tubulointerstitial disease is not known. In this grant application, we demonstrate that in over half of patients, the tubulointerstitial inflammatory infiltrate is organized into either well-circumscribed T:B cell aggregates or germinal centers (GCs) containing follicular dendritic cells. Sampling of in situ expressed immunoglobulins using laser capture microscopy coupled to RT-PCR revealed a restricted repertoire in both histological patterns that likely arose from local clonal expansion. Furthermore, the pattern of somatic hypermutations in GC expressed immunoglobulins was consistent with ongoing antigen-driven selection. The presence of either T:B aggregates or GCs was strongly associated with more severe tubulointerstitial inflammation and the deposition of immune complexes in tubular basement membranes. These observations raise the novel possibility that lupus tubulointerstitial nephritis is not a manifestation of systemic autoimmunity to ubiquitous autoantigens. Rather, it might result from a break in tolerance to locally expressed antigens. In this grant application, we hypothesize that in lupus nephritis, in situ selected B cells secrete autoreactive antibodies which deposit in the tubulointerstitium and contribute to local inflammation. This hypothesis will be tested in the following Specific Aims: Aim 1. To characterize in situ B cell responses in lupus nephritis biopsies manifesting the diffuse, T:B aggregate and GC histological patterns. Aim 2: To determine the origin of the in situ B cell repertoire in lupus nephritis. In Aim 3: To identify the antigenic specificities of in situ expressed antibodies in SLE nephritis. PUBLIC HEALTH RELEVANCE The most prevalent, severe manifestation of systemic lupus erythematosus is nephritis. Recently, we have demonstrated that tertiary lymphoid neogenesis is a common feature of lupus nephritis that is associated with severe tubulointerstitial inflammation. In this application, we will determine if tubulointerstitial nephritis results from a local break in tolerance and the development of in situ immune responses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Comprehensive characterization of immune signaling networks in single-cells by joint quantification of proteins, protein complexes and mRNA
-
批准号:10636695
-
项目类别:
-
资助金额:$67.31万
-
财政年份:2023
-
负责人:Marcus Ramsay Clark
-
依托单位:
Medical Scientist National Research Service Award
-
批准号:10869820
-
项目类别:
-
资助金额:$17.42万
-
财政年份:2023
-
负责人:Marcus Ramsay Clark
-
依托单位:
Medical Scientist National Research Service Award
-
批准号:10703834
-
项目类别:
-
资助金额:$127.72万
-
财政年份:2023
-
负责人:Marcus Ramsay Clark
-
依托单位:
Role of CXCR4 in immunoglobulin light chain recombination
-
批准号:10569055
-
项目类别:
-
资助金额:$57.96万
-
财政年份:2021
-
负责人:Marcus Ramsay Clark
-
依托单位:
Role of CXCR4 in immunoglobulin light chain recombination
-
批准号:10117864
-
项目类别:
-
资助金额:$57.96万
-
财政年份:2021
-
负责人:Marcus Ramsay Clark
-
依托单位:
Role of CXCR4 in immunoglobulin light chain recombination
-
批准号:10368138
-
项目类别:
-
资助金额:$57.96万
-
财政年份:2021
-
负责人:Marcus Ramsay Clark
-
依托单位:
The epigenetic reader BRWD1 in peripheral adaptive immunity
-
批准号:10541126
-
项目类别:
-
资助金额:$48.78万
-
财政年份:2019
-
负责人:Marcus Ramsay Clark
-
依托单位:
The epigenetic reader BRWD1 in peripheral adaptive immunity
-
批准号:10077826
-
项目类别:
-
资助金额:$48.78万
-
财政年份:2019
-
负责人:Marcus Ramsay Clark
-
依托单位:
The epigenetic reader BRWD1 in peripheral adaptive immunity
-
批准号:10321252
-
项目类别:
-
资助金额:$48.78万
-
财政年份:2019
-
负责人:Marcus Ramsay Clark
-
依托单位:
BRWD1 in adaptive humoral immunity
-
批准号:9307294
-
项目类别:
-
资助金额:$24.19万
-
财政年份:2017
-
负责人:Marcus Ramsay Clark
-
依托单位:
BRWD1 in adaptive humoral immunity
-
批准号:9413989
-
项目类别:
-
资助金额:$20.25万
-
财政年份:2017
-
负责人:Marcus Ramsay Clark
-
依托单位:
Regulation of Ig-kappa recombination during B lymphopoiesis
-
批准号:9257272
-
项目类别:
-
资助金额:$46.19万
-
财政年份:2015
-
负责人:Marcus Ramsay Clark
-
依托单位:
Regulation of Ig-kappa recombination during B lymphopoiesis
-
批准号:9474100
-
项目类别:
-
资助金额:$46.19万
-
财政年份:2015
-
负责人:Marcus Ramsay Clark
-
依托单位:
In situ tolerance in autoimmunity
-
批准号:8732778
-
项目类别:
-
资助金额:$7.9万
-
财政年份:2014
-
负责人:Marcus Ramsay Clark
-
依托单位:
In vivo functions of Ig-beta ubiquitinylation
-
批准号:8976272
-
项目类别:
-
资助金额:$29.6万
-
财政年份:2012
-
负责人:Marcus Ramsay Clark
-
依托单位:
In vivo functions of Ig-beta ubiquitinylation
-
批准号:8436646
-
项目类别:
-
资助金额:$29.6万
-
财政年份:2012
-
负责人:Marcus Ramsay Clark
-
依托单位:
In vivo functions of Ig-beta ubiquitinylation
-
批准号:8595320
-
项目类别:
-
资助金额:$29.6万
-
财政年份:2012
-
负责人:Marcus Ramsay Clark
-
依托单位:
In vivo functions of Ig-beta ubiquitinylation
-
批准号:8824783
-
项目类别:
-
资助金额:$2.96万
-
财政年份:2012
-
负责人:Marcus Ramsay Clark
-
依托单位:
Regulation of cyclin D3 in B lymphocyte development
-
批准号:7983829
-
项目类别:
-
资助金额:$31.65万
-
财政年份:2010
-
负责人:Marcus Ramsay Clark
-
依托单位:
Regulation of cyclin D3 in B lymphocyte development
-
批准号:8134331
-
项目类别:
-
资助金额:$29.94万
-
财政年份:2010
-
负责人:Marcus Ramsay Clark
-
依托单位:
海外基金